nephSAP: Volume 13
68
3.3MB
A diagnosis of antiphospholipid syndrome (APS) is most often considered in patients with autoimmune diseases (e.g., SLE) who develop unexplained and recurrent pregnancy loss, unexplained and recurrent episodes of thrombosis, or acute multiorgan failure wi
→
Volume 13, Number 1, January 2014
Vaso-Occlusive Disorders and Kidney Disease
Patrick H. Nachman, MD, William F. Clark, MD, and Vimal Derebail, MD
AMA PRA Category 1 Credits™
A diagnosis of antiphospholipid syndrome (APS) is most often considered in patients with autoimmune diseases (e.g., SLE) who develop unexplained and recurrent pregnancy loss, unexplained and recurrent episodes of thrombosis, or acute multiorgan failure wi...
88
3.6MB
The emergence of favorable therapeutic outcomes from device-based treatments and antihypertensive therapy has fueled increased interest in resistant hypertension over the past 5 years.
→
Volume 13, Number 2, March 2014
Hypertension
Raymond R. Townsend, MD and Aldo J. Peixoto, MD
AMA PRA Category 1 Credits™
The emergence of favorable therapeutic outcomes from device-based treatments and antihypertensive therapy has fueled increased interest in resistant hypertension over the past 5 years....
78
4.3MB
CKD–mineral and bone disorder (CKD-MBD) is a complex syndrome of disordered mineral and bone metabolism that occurs as kidney function declines. Renal osteodystrophy (ROD) is one bone manifestation of CKD-MBD, and is associated with excess fracture risk.
→
Volume 13, Number 3, July 2014
Disorders of Divalent Ions, Renal Bone Disease and Nephrolithiasis
Stanley Goldfarb, MD and Kevin J. Martin, MBBCh
AMA PRA Category 1 Credits™
CKD–mineral and bone disorder (CKD-MBD) is a complex syndrome of disordered mineral and bone metabolism that occurs as kidney function declines. Renal osteodystrophy (ROD) is one bone manifestation of CKD-MBD, and is associated with excess fracture risk. ...
124
3MB
Although the recent global explosion of interest and new data on primary glomerular disorders has yielded significant advances in our understanding of these disorders, there remains a chasm of uncertainty that provides our profession both great challenges
→
Volume 13, Number 4, September 2014
Glomerular, Vascular, and Tubulointerstistial Diseases
Richard J. Glassock, MD and Patrick H. Nachman, MD
AMA PRA Category 1 Credits™
Although the recent global explosion of interest and new data on primary glomerular disorders has yielded significant advances in our understanding of these disorders, there remains a chasm of uncertainty that provides our profession both great challenges...
110
4.7MB
Between January 2010 and October 2012, monthly Medicare prevalent counts of patients on peritoneal dialysis (PD) increased by 24.0%, whereas prevalent counts of patients on hemodialysis (HD) increased by 9.6% (1).
→
Volume 13, Number 5, November 2014
End Stage Renal Disease and Dialysis
Ruediger W. Lehrich, MD and John P. Middleton, MD
AMA PRA Category 1 Credits™
Between January 2010 and October 2012, monthly Medicare prevalent counts of patients on peritoneal dialysis (PD) increased by 24.0%, whereas prevalent counts of patients on hemodialysis (HD) increased by 9.6% (1)....
